干扰素γ释放试验评估SARS-CoV-2感染或疫苗接种后T细胞免疫的初步研究
该初步研究在COVID-19暴发后的修道院封闭人群中,对121名受试者采用化学发光微粒子免疫分析法检测spike IgG和核衣壳IgG,并用两种SARS-CoV-2刺突蛋白抗原混合物进行干扰素γ释放试验。结果显示,接种两剂疫苗者IgG和干扰素γ浓度最高,干扰素γ试验最佳cutoff为25 IU/L。
要点
- 接种两剂疫苗者干扰素γ浓度最高,其次为未接种的既往感染者。
- 干扰素γ试验在所有亚组和两种抗原中最佳cutoff均为25 IU/L。
- T细胞应答检测可能有助于评估SARS-CoV-2暴露后的免疫保护。
核心结论
- 干扰素γ释放试验可用于评估SARS-CoV-2感染或疫苗接种后的T细胞免疫,25 IU/L为最佳cutoff。
研究设计与样本
- 在COVID-19暴发后的修道院封闭机构中研究121名受试者,采用Architect平台化学发光微粒子免疫分析法检测IgG,并对部分受试者进行两种SARS-CoV-2刺突蛋白抗原混合物的干扰素γ释放试验。
主要发现
- 接种两剂疫苗者spike IgG水平和干扰素γ浓度最高,其次为有较长既往COVID-19病史且未接种疫苗者。
- 干扰素γ试验在所有个体亚组和两种SARS-CoV-2抗原中最佳cutoff均为25 IU/L。
关键数值与推荐
- 干扰素γ试验最佳cutoff为25 IU/L,适用于所有亚组和两种抗原。
临床怎么用
- T细胞应答检测可能有助于确定SARS-CoV-2抗原暴露后的免疫状态,可采用25 IU/L作为干扰素γ试验的cutoff。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Assessment of T-cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens may be of value to determine long-lasting protection to breakthrough infections or reinfections. Interferon gamma release assay is a validated method to test cellular immunity in mycobacterial infections and has been proposed for patients with SARS-CoV-2 infection or vaccination. Quantitative IgG to spike and qualitative IgG to nucleocapsid antigens were determined by chemiluminescence microparticle immunoassay using the Architect platform (Abbott), and interferon gamma release assays against two Qiagen proprietary mixes of SARS-CoV-2 spike protein (antigen 1 and antigen 2) were performed for a selected group of subjects. A total of 121 subjects in a cloistered institution after a COVID-19 outbreak was studied. IgG spike levels and interferon gamma concentrations were highest among subjects after two doses of vaccine, followed by patients with a longer history of past COVID-19 and no vaccination. The best cutoff for the interferon gamma assay was 25 IU/L for all subgroups of individuals and the two sets of SARS-CoV-2 antigens studied. Testing T-cell response may be of clinical utility to determine immunity after exposure to SARS-CoV-2 antigens, with the interferon gamma concentration of 25 IU/L as the best cutoff either after infection or vaccination.
引用
- Barreiro P, Sanz JC, San Román J, et al. A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort. J Clin Microbiol. 2022. PMID: 35020419. doi:10.1128/jcm.02199-21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。